Afatinib Completed Phase 1 Trials for Liver Diseases / Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01298063Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib
NCT02171754Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy Volunteers
NCT01426958Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects
NCT01396265Drug Interaction Study With Rifampicin and Afatinib